Whitehawk Therapeutics, Inc. · NASDAQ:WHWK
BEHZAD AGHAZADEH reported a 14.50% stake in Whitehawk Therapeutics, Inc. (Schedule 13D/A)
Event Dec 19, 2024 · Filed Dec 23, 2024
BEHZAD AGHAZADEH reported a 14.50% stake in Whitehawk Therapeutics, Inc., 3,581,961 shares, with active intent on Dec 19, 2024. Filed Dec 23, 2024 (Schedule 13D/A).
- Stake
- 14.50%
- Shares
- 3,581,961
- Intent
- Active
- What changed
- Stake changed
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| AVORO CAPITAL ADVISORS LLC | 11.60% | 2,849,402 |
| AVORO VENTURES LLC | 2.50% | 622,350 |
| BEHZAD AGHAZADEH | 14.50% | 3,581,961 |
Source
Related
- Whitehawk Therapeutics, Inc.
- Behzad Aghazadeh
- Whitehawk Therapeutics, Inc. shareholders
- Schedule 13D/A · Behzad Aghazadeh · Mar 4, 2025
- Schedule 13G/A · Fan Yu · Aug 14, 2026
- Schedule 13G/A · Orbimed Advisors LLC · Aug 14, 2026
- Form 4 · Dalal Anupam · Jul 30, 2026
- Form 4 · Dugan Margaret · May 18, 2026
- Form 4 · Ball Bryan · May 18, 2026